Rigorous Realities – Enhanced Expectations in the Air Cargo Cold Chain

Add bookmark

Tom Grubb

Advancements in pharmaceuticals are changing the face of 21st century medicine, giving patients around the world access to new life-saving drugs and vaccines. Because many of these innovative pharma and biopharma products are temperature-sensitive, the growing global pharmaceutical market is driving demand for cold chain logistics. By 2018, the worldwide biopharmaceutical market is expected to reach sales of $177 billion, according to the research firm IMARC Group. With so much at stake – both a...
To continue reading this story get free access